Membrane complement regulatory proteins

被引:262
作者
Kim, DD [1 ]
Song, WC [1 ]
机构
[1] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
关键词
CD55; CD46; CD59; Crry; MCP; DAF; CR1; membrane complement regulators;
D O I
10.1016/j.clim.2005.10.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A number of proteins anchored on the cell surface function to protect host tissues from bystander injury when complement is activated. In humans, they include decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46), complement receptor 1 (CR1, CD35) and CD59. Although disease conditions directly attributable to abnomial function of these proteins are relatively rare, it has become evident from recent studies using animal models that membrane complement regulatory proteins are important modulators of tissue injury in many autoimmune and inflammatory disease settings. Evidence is also emerging to support a role of these proteins in regulating cellular immunity. In this article, we highlight recent advances on the in vivo biology of membrane complement regulatory proteins and discuss their relevance in human disease pathogenesis and therapeutics. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 122 条
[1]   Molecular basis for a link between complement and the vascular complications of diabetes [J].
Acosta, J ;
Hettinga, J ;
Flückiger, R ;
Krumrei, N ;
Goldfine, A ;
Angarita, L ;
Halperin, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5450-5455
[2]   STRUCTURE AND FUNCTION OF THE COMPLEMENT RECEPTORS, CR-1 (CD35) AND CR-2 (CD21) [J].
AHEARN, JM ;
FEARON, DT .
ADVANCES IN IMMUNOLOGY, 1989, 46 :183-219
[3]   Decay-accelerating factor induction by tumour necrosis factor-α, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition [J].
Ahmad, SR ;
Lidington, EA ;
Ohta, R ;
Okada, N ;
Robson, MG ;
Davies, KA ;
Leitges, M ;
Harris, CL ;
Haskard, DO ;
Mason, JC .
IMMUNOLOGY, 2003, 110 (02) :258-268
[4]   The role of the complement system in ischemia-reperfusion injury [J].
Arumugam, TV ;
Shiels, IA ;
Woodruff, TM ;
Granger, DN ;
Taylor, SM .
SHOCK, 2004, 21 (05) :401-409
[5]   Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection [J].
Atkinson, C ;
Song, HB ;
Lu, B ;
Qiao, F ;
Burns, TA ;
Holers, VM ;
Tsokos, GC ;
Tomlinson, S .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (09) :2444-2453
[6]  
Austen WG, 2003, INT J IMMUNOPATH PH, V16, P1
[7]   CD59a is the primary regulator of membrane attack complex assembly in the mouse [J].
Baalasubramanian, S ;
Harris, CL ;
Donev, RM ;
Mizuno, M ;
Omidvar, N ;
Song, WC ;
Morgan, BP .
JOURNAL OF IMMUNOLOGY, 2004, 173 (06) :3684-3692
[8]   Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood [J].
Banz, Y ;
Cung, T ;
Korchagina, EY ;
Bovin, NV ;
Haeberli, A ;
Rieben, R .
XENOTRANSPLANTATION, 2005, 12 (06) :434-443
[9]   Complement and atherogenesis - Binding of CRP to degraded, nonoxidized LDL enhances complement activation [J].
Bhakdi, S ;
Torzewski, M ;
Klouche, M ;
Hemmes, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2348-2354
[10]   Ischaemia-reperfusion is an event triggered by immune complexes and complement [J].
Chan, RK ;
Ibrahim, SI ;
Verna, N ;
Carroll, M ;
Moore, FD ;
Hechtman, HB .
BRITISH JOURNAL OF SURGERY, 2003, 90 (12) :1470-1478